General Description

Enveric Biosciences

Youtube Subscribe

Ticker: ENVB

Sector: Biotechnology

Enveric Biosciences has agreed to sell one of its cancer-related patent portfolios. The sale represents a strategic pivot towards prioritizing mental health treatments over oncology..

Extended Summary

Enveric Biosciences

Enveric Biosciences has agreed to sell one of its patent portfolios that links cannabidiol and second therapeutic agents for the treatment of cancer. The sale represents a strategic pivot towards prioritizing mental health treatments over oncology assets. Enveric Biosciences is a development stage company that markets no products at this time. The company specializes in the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, and addiction disorders. Enverics decision to sell one of their cancer-related patent portfolios marks a strategic move.

Related Results

February 24, 2024 14:18 (London Time)